论文部分内容阅读
第四军医大学王克为教授等研制成功的地龙胶囊近日通过专家鉴定。 地龙胶囊又名912,是用低温法从背暗翼唇蚓中提取经冻干的混合物胶囊,其制备方法属国内外首创。实验研究证明,该药对动物肿瘤抑制率达99％,对肿瘤的放、化疗和热疗有显著增效作用。经对625例癌症患者口服观察表明,对晚期食管癌总缓解率达43％;合并化疗对肺癌
The Fourth Military Medical University Professor Wang Kewei successfully developed Dilong capsule recently passed expert assessment. Dilong Capsule, also known as 912, is a lyophilized mixture capsule extracted from the dorsal, venomous, dorsal, dark-wing, by a cryogenic method. Its preparation method is the first of its kind in the world. Experimental studies have shown that the drug on animal tumor inhibition rate of 99% on the tumor radiotherapy, chemotherapy and hyperthermia have significant synergies. Oral observation of 625 cancer patients showed that the total remission rate of advanced esophageal cancer was 43%; chemotherapy combined with lung cancer